Causes, Not Just Cases® | The Motley Rice Law Blog

Filter By

Clear Filters

December 19, 2014

Trouble with Tylenol®: Even common OTC medication should be taken with care

When the risk of severe, potentially deadly skin reactions is found in association with one of the most widely used over-the-counter medications, you would think that warning the public would be a priority. But a year and a half after publishing an initial consumer update on the risk, the FDA is only now asking that a warning be placed on all acetaminophen-containing medications, including over-the-counter drugs.

Read More

December 3, 2014

Is the grass really greener for afib sufferers taking Xarelto?

The FDA approved Xarelto (generic name: rivaroxaban) as a blood thinner for atrial fibrillation patients in November of 2011. What you don’t read about as often is that, along with a high volume of adverse events being reported, 1) the FDA’s own review of the drug recommended against its approval and 2) Xarelto currently has no antidote.

Read More